Treating sleep disorders using desloratadine
US6114346A · kind A · utility
22Cited by
24References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 1999 |
| Grant date | Sep 5, 2000 |
| Priority date | — |
| Expiry date | Oct 22, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating and/or preventing sleep disorders in a human afflicted with upper airway passage allergic inflammation and/or congestion associated with allergic rhinitis, including seasonal allergic rhinitis or perennial allergic rhinitis by administering a therapeutically effective amount of desloratadine, alone or in combination with other active agents such as a decongestant as pseudoephedrine are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.